CN1223119A - Traditional Chinese medicinal preparation for curing gynecopathy - Google Patents

Traditional Chinese medicinal preparation for curing gynecopathy Download PDF

Info

Publication number
CN1223119A
CN1223119A CN97120991A CN97120991A CN1223119A CN 1223119 A CN1223119 A CN 1223119A CN 97120991 A CN97120991 A CN 97120991A CN 97120991 A CN97120991 A CN 97120991A CN 1223119 A CN1223119 A CN 1223119A
Authority
CN
China
Prior art keywords
radix
root
rhizoma
chinese medicinal
curcumae
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN97120991A
Other languages
Chinese (zh)
Other versions
CN1078078C (en
Inventor
蔡利珊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cai Lishan
Dihon Pharmaceutical Group Co Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN97120991A priority Critical patent/CN1078078C/en
Publication of CN1223119A publication Critical patent/CN1223119A/en
Application granted granted Critical
Publication of CN1078078C publication Critical patent/CN1078078C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention provides an oral Chinese medicine preparation for curing the diseases of dysmenorrhea, irregular menstruation, menstrual molimen and female sterility, etc. Its raw material composition includes the Chinese medicinal materials of red sage root, zedoary, bupleurum root, red peony root, Chinese angelica root, burreed tuber, nutgrass flatsedge rhizome, corydalis tuber, trogopterus dung, achyranthes root, curcuma root, licorice and notoginseng. The tests show that its total effective rate is 92.5%, in which cure rate is 22.3%, effectual rate is 35.8%, and it has no toxic side effect.

Description

The gynecopathy Chinese medicine preparation
The present invention relates to a kind of Chinese medicine preparation that is used for the treatment of endometriosis.
Chinese patent application CN1123178A (application number 95111058.6) discloses " a kind of treatment endometriosis Chinese medicine preparation, preparation and processing technology ", and it mainly is made up of Rhizoma Chuanxiong, Radix Angelicae Sinensis, the Radix Paeoniae Alba, Rhizoma Curcumae, Herba Artemisiae Annuae, the Radix Astragali, Herba Epimedii, Radix Achyranthis Bidentatae.
Chinese patent application CN1081107A (application number 93110326.6) discloses a kind of " medicine for endometriosis and manufacturing process thereof ", is to adopt Rhizoma Cyperi, Rhizoma Corydalis, Ramulus Cinnamomi, Radix Salviae Miltiorrhizae, rhizoma sparganic, Rhizoma Curcumae to make.Above-mentioned two kinds of medicines all are mainly to treat endometriosis, but the former prescription is based on Rhizoma Chuanxiong, Radix Angelicae Sinensis, the Radix Paeoniae Alba, Rhizoma Curcumae, and the latter also has only 6 flavor medicines, and whole prescription seems thin, acts on incomplete.
Purpose of the present invention aims to provide a kind of pure Chinese medicinal preparation for the treatment of endometriosis.
Gynecopathy Chinese medicine preparation composition of the present invention is: Radix Salviae Miltiorrhizae 10-45g, Rhizoma Curcumae 8-20g, Radix Bupleuri 10-20g, Radix Paeoniae Rubra 10-20g, Radix Angelicae Sinensis 10-30g, rhizoma sparganic 6-20g, Rhizoma Cyperi 6-15g, Rhizoma Corydalis 6-15g, Oletum Trogopterori 6-20g, Radix Achyranthis Bidentatae 10-30g, Radix Curcumae 10-30g, Radix Glycyrrhizae 4-20g, Radix Notoginseng 3-30g make oral formulations.
Among the above-mentioned side, the Radix Salviae Miltiorrhizae hardship is slightly cold, and goes into the conscience warp, the promoting the circulation of blood stasis of blood, menstruction regulating and pain relieving; The Radix Paeoniae Rubra nature and flavor are bitter, cool, go into the liver spleen channel, clots absorbing, pain relieving, removing heat from blood, detumescence; The cold that is slightly cold of Radix Bupleuri hardship is gone into the liver and gall warp, reconciling superficies and interior, soothing liver-QI, resolving depression regulating menstruation; The Radix Curcumae toil is sweet cold, goes into the cardiopulmonary Liver Channel, removing heat from blood removing blood stasis with potent drugs, promoting QI circulation for relieving depression, promoting blood circulation and stopping pain; Rhizoma Curcumae toil temperature is gone into Liver Channel, the circulation of qi promoting removing blood stasis, and eliminate indigestion disappears, pain relieving; Rhizoma sparganic is arduous, goes into the liver spleen channel, the circulation of qi promoting removing blood stasis, and the removing food stagnancy pain relieving is stimulated the menstrual flow; Radix Glycyrrhizae property is sweet flat, goes into the taste lung meridian, invigorating middle warmer emergency, detoxifcation is arranged, the effect of coordinating the actions of various ingredients in a prescription.Radix Paeoniae Rubra can replace with Radix Paeoniae Alba 10-20g in the side, and Radix Angelicae Sinensis can replace with Rhizoma Chuanxiong 10-15g, and Rhizoma Cyperi can replace with Radix Aucklandiae 6-15g, and Oletum Trogopterori can replace with Pollen Typhae 10-15g, and Rhizoma Corydalis can replace with Olibanum 10-15g, and rhizoma sparganic can replace with Pheretima 10-20g.
Principal agent is gone into Liver Channel in the prescription of the present invention, and the effect of QI and blood regulating is arranged, and the medicine that has is double goes into kidney channel, nurses one's health congenitally, and some medicines are double goes into spleen channel, conditioning day after tomorrow.Full presciption medicine is neither cold and cool, and also partial heat not focuses on dispersing the stagnated live-QI to relieve the stagnation of QI, promoting flow of QI and blood, and analgesic effect is stronger, includes promoting the circulation of QI to relieve pain, promoting blood circulation and stopping pain and stasis-dispelling and pain-killing, menstruction regulating and pain relieving.Modern medicine study thinks that this type of medicine has the effect of regulating body's immunity.
Pure Chinese medicinal preparation of the present invention can be used for the treatment with dysmenorrhea, menoxenia, menstrual period discomfort, sexual anhedonia, pelvic pain, infertile grade is the endometriosis of clinical symptoms.Prove that through animal pharmacology, pharmacodynamics test this Chinese medicine preparation has no side effect, have to make that Ectopic Endometrium atrophy, body of gland dwindle, the effect of tissue necrosis.Through the clinical case test, total effective rate is 92.5%, wherein fully recovers 22.3%, produce effects 35.8%, effective 34.4%.This Chinese medicine preparation can be made into multiple dosage form, as mixture, tablet, extractum, capsule and ball, loose etc., is convenient to take.
Embodiment:
1, get Radix Salviae Miltiorrhizae 15g, Rhizoma Curcumae 8g, Radix Bupleuri 10g, Radix Paeoniae Rubra 10g, Radix Angelicae Sinensis 12g, rhizoma sparganic 8g, Rhizoma Cyperi 8g, Rhizoma Corydalis 6g, Oletum Trogopterori 8g, Radix Achyranthis Bidentatae 10g, Radix Curcumae 10g, Radix Glycyrrhizae 4g, Radix Notoginseng 3g, fragmentation, water decocts, and makes the 250ml mixture.
2, get Radix Salviae Miltiorrhizae 25g, Rhizoma Curcumae 10g, Radix Bupleuri 13g, Radix Paeoniae Rubra 18g, Radix Angelicae Sinensis 30g, rhizoma sparganic 12g, Rhizoma Cyperi 6g, Rhizoma Corydalis 10g, Oletum Trogopterori 14g, Radix Achyranthis Bidentatae 20g, Radix Curcumae 15g, Radix Glycyrrhizae 12g, Radix Notoginseng 5g, the Radix Notoginseng pulverizing is stand-by, Radix Salviae Miltiorrhizae, Rhizoma Curcumae alcohol extraction are stand-by, all the other waters decoct, concentrate, add the Radix Notoginseng, Radix Salviae Miltiorrhizae, the Rhizoma Curcumae that have prepared, obtain extractum.

Claims (1)

1, a kind of gynecopathy Chinese medicine preparation, it is characterized in that described preparation composition is: Radix Salviae Miltiorrhizae 10-45g, Rhizoma Curcumae 8-20g, Radix Bupleuri 10-20g, Radix Paeoniae Rubra 10-20g, Radix Angelicae Sinensis 10-30g, rhizoma sparganic 6-20g, Rhizoma Cyperi 6-15g, Rhizoma Corydalis 6-15g, Oletum Trogopterori 6-20g, Radix Achyranthis Bidentatae 10-30g, Radix Curcumae 10-30g, Radix Glycyrrhizae 4-20 g, Radix Notoginseng 3-30g, described preparation is an oral formulations.
CN97120991A 1997-12-05 1997-12-05 Traditional Chinese medicinal preparation for curing gynecopathy Expired - Lifetime CN1078078C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN97120991A CN1078078C (en) 1997-12-05 1997-12-05 Traditional Chinese medicinal preparation for curing gynecopathy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN97120991A CN1078078C (en) 1997-12-05 1997-12-05 Traditional Chinese medicinal preparation for curing gynecopathy

Publications (2)

Publication Number Publication Date
CN1223119A true CN1223119A (en) 1999-07-21
CN1078078C CN1078078C (en) 2002-01-23

Family

ID=5176118

Family Applications (1)

Application Number Title Priority Date Filing Date
CN97120991A Expired - Lifetime CN1078078C (en) 1997-12-05 1997-12-05 Traditional Chinese medicinal preparation for curing gynecopathy

Country Status (1)

Country Link
CN (1) CN1078078C (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101537095A (en) * 2009-04-29 2009-09-23 北京星昊医药股份有限公司 Traditional Chinese medicine composition used for gynae regulating the menstrual function
CN102671108A (en) * 2011-03-07 2012-09-19 中国中医科学院广安门医院 Applications for traditional Chinese medicine pharmaceutical composition
CN105056129A (en) * 2015-08-17 2015-11-18 青岛云天生物技术有限公司 Traditional Chinese medicine preparation for treating endometriosis and preparation method thereof
CN108272936A (en) * 2018-01-29 2018-07-13 王学奎 A kind of the drug composition and preparation method of palace of the Qing Dynasty blood stasis removing pill

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1081107A (en) * 1992-03-16 1994-01-26 山东青岛中西医结合医院 Medicine for endometriosis and manufacturing process thereof
CN1048900C (en) * 1995-06-05 2000-02-02 中国人民解放军南京军区南京总医院 Formula of traditional Chinese medicine for curing endometriosis and preparation and preparation technology thereof

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101537095A (en) * 2009-04-29 2009-09-23 北京星昊医药股份有限公司 Traditional Chinese medicine composition used for gynae regulating the menstrual function
CN102671108A (en) * 2011-03-07 2012-09-19 中国中医科学院广安门医院 Applications for traditional Chinese medicine pharmaceutical composition
CN102671108B (en) * 2011-03-07 2014-03-19 中国中医科学院广安门医院 Applications for traditional Chinese medicine pharmaceutical composition
CN105056129A (en) * 2015-08-17 2015-11-18 青岛云天生物技术有限公司 Traditional Chinese medicine preparation for treating endometriosis and preparation method thereof
CN108272936A (en) * 2018-01-29 2018-07-13 王学奎 A kind of the drug composition and preparation method of palace of the Qing Dynasty blood stasis removing pill

Also Published As

Publication number Publication date
CN1078078C (en) 2002-01-23

Similar Documents

Publication Publication Date Title
CN103784820B (en) For treating Chinese medicine formula and the Chinese medicinal capsule of cardiovascular stasis coronary heart disease
CN103341004B (en) Chinese medicine composition for treating delayed menstrual cycle
CN104667070A (en) Medicine for treating skin diseases and preparation method of medicine
CN103599496B (en) Traditional Chinese medicine for treatment of chronic gastritis
CN103463586A (en) Traditional Chinese medicine composition for treating restless legs syndrome
CN104623376B (en) Be used for the treatment of prosopalgic medicine
CN1078078C (en) Traditional Chinese medicinal preparation for curing gynecopathy
CN103550715B (en) Traditional Chinese medicine for treating bronchitis
CN106110108A (en) A kind of Miao Ethnomedicine treating chronic hepatitis
CN104958525A (en) Traditional Chinese medicine composition for treating chronic infectious arthritis and preparation method of traditional Chinese medicine composition
CN104587131A (en) Traditional Chinese medicinal composition for treating delayed menorrhea
CN104645163A (en) Traditional Chinese medicine composition for treating psoriasis
CN104587385A (en) Traditional Chinese medicine composition for treating blood stasis condensation type rosacea
CN104069421A (en) Traditional Chinese medicine composition for treating heart diseases
CN103212033B (en) Drug composition for treating viral hepatitis
CN108567926B (en) Traditional Chinese medicine composition for treating blood stasis collateral blocking type autoimmune hepatitis and preparation method thereof
CN105748816A (en) Medicine for treating fallopian tube obstruction
CN102423367B (en) Beautifying and blood-activating medicament
CN102038926A (en) Traditional Chinese medicine preparation for treating dysmenorrhea
CN1382486A (en) Fengshitongluo wan for treating rheumatism
CN105250938A (en) Drug for damp-heat type cirrhotic ascites
CN105617178A (en) Traditional Chinese medicine composition for treating epidemic parotitis
CN117357610A (en) Traditional Chinese medicine composition for improving male sexual function and application thereof
CN104887874A (en) Traditional Chinese medicine composition for treating pneumonia
CN105194337A (en) Medicine for treating idiopathic tubulointerstitial nephritis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: CAI LISHAN

Free format text: FORMER OWNER: NONE

Effective date: 20030919

Owner name: KUMING DIANHONG PHARMACEUTICAL CO., LTD.

Free format text: FORMER OWNER: CAI LISHAN

C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20030919

Address after: 650106 No. 45, medical Road, hi tech Development Zone, Yunnan, Kunming

Co-patentee after: Cai Lishan

Patentee after: Kuning Dianhong Pharmaceutical Co., Ltd.

Address before: 650101 the Second Affiliated Hospital of Kunming Medical University, 1 Ma Yuan Garden, Kunming, Yunnan

Patentee before: Cai Lishan

EE01 Entry into force of recordation of patent licensing contract

Assignee: Shanghai Dihon Pharmaceutical Co., Ltd.

Assignor: Kuning Dianhong Pharmaceutical Co., Ltd.|Cai Lishan

Contract fulfillment period: 2009.10.25 to 2017.12.5 contract change

Contract record no.: 2009530000047

Denomination of invention: Traditional Chinese medicinal preparation for curing gynecopathy

Granted publication date: 20020123

License type: General permission

Record date: 2009.12.2

LIC Patent licence contract for exploitation submitted for record

Free format text: COMMON LICENSE; TIME LIMIT OF IMPLEMENTING CONTACT: 2009.10.25 TO 2017.12.5; CHANGE OF CONTRACT

Name of requester: SHANGHAI DIHON PHARMACEUTICAL CO., LTD.

Effective date: 20091202

C56 Change in the name or address of the patentee

Owner name: DIHON PHARMACEUTICAL GROUP CO., LTD.

Free format text: FORMER NAME: KUNING DIANHONG PHARMACEUTICAL CO., LTD.

CP01 Change in the name or title of a patent holder

Address after: 650106 Kunming science and Technology Development Zone, Yunnan Province Road No. 45

Co-patentee after: Cai Lishan

Patentee after: Dihon Pharmaceutical Group Co., Ltd.

Address before: 650106 Kunming science and Technology Development Zone, Yunnan Province Road No. 45

Co-patentee before: Cai Lishan

Patentee before: Kuning Dianhong Pharmaceutical Co., Ltd.

CX01 Expiry of patent term
CX01 Expiry of patent term

Granted publication date: 20020123